HANGZHOU, China, Jan. 22, 2018 /PRNewswire/ -- Hangzhou Just Biotherapeutics ("HJB"), an organization dedicated to expanding
Jonathan Y. Zhao, Founder and CEO of HJB, delivered a speech at the opening ceremony. He reviewed the progress HJB has made since its establishment, and stressed that "HJB has reached another important milestone. This is a great step towards our mission of expanding global access to biotherapeutics. We will further leverage the 3rd-generation biologics platform to develop and manufacture high quality biologics for patients around the world."
Jonathan Y. Zhao, Jim Thomas and two other senior executives from Amgen co-founded Just Biotherapeutics Inc. in Seattle in 2015. Subsequently, its sister company, HJB, was established in China in August 2016. So far, both companies employ nearly 200 scientists and engineers.
Over the past two years, HJB has secured a total of USD 67 million in financing from Lilly Asia Ventures, ARCH Venture Partners, Temasek, Taikang, HEDA and other investors, and has grown rapidly. HJB completed the 140,000 sq.ft R&D Center and GMP Manufacturing Facility which will supply the global market with clinical and commercial product.
View original content:http://www.prnewswire.com/news-releases/hangzhou-just-biotherapeutics-opens-rd-center-and-gmp-manufacturing-facility-to-develop-biologic-medicines-globally-300585757.html
SOURCE Hangzhou Just Biotherapeutics, Ltd.
Subscribe to our Free Newsletters!
Trichotillomania is a hair pulling disorder where a person urges to pull out hair from their scalp, ...
Dental Anxiety is kind of dental phobia where a person has a fear of going to dentist mainly due to ...
Kleine Levin (KLS) or sleeping beauty syndrome is a rare neurological disorder that primarly ...View All